Prostate Health Index and %p2PSA Predict Aggressive Prostate Cancer Pathology in Chinese Patients Undergoing Radical Prostatectomy

被引:21
作者
Chiu, Peter Ka-Fung [1 ]
Lai, Fernand Mac-Moune [2 ]
Teoh, Jeremy Yuen-Chun [1 ]
Lee, Wai-Man [1 ]
Yee, Chi-Hang [1 ]
Chan, Eddie Shu-Yin [1 ]
Hou, See-Ming [1 ]
Ng, Chi-Fai [1 ,3 ]
机构
[1] Chinese Univ Hong Kong, Dept Surg, Div Urol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Surg, SH Ho Urol Ctr, Shatin, Hong Kong, Peoples R China
关键词
BIOPSY; MULTICENTER; ANTIGEN; NG/ML; DERIVATIVES; OUTCOMES; ISOFORM; RANGE;
D O I
10.1245/s10434-016-5183-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the performance of prostate health index (PHI) and percentage prostate-specific antigen (PSA) isoform [-2]proPSA (%p2PSA) in predicting pathologic outcomes at radical prostatectomy (RP) in a Chinese population. We performed a prospective study of 135 prostate cancer patients with RP. The accuracy of preoperative %p2PSA (= p2PSA/free PSA) and PHI [= (p2PSA/free PSA) x aePSA] in predicting pathologic outcomes of RP including pT3 disease, pathologic Gleason score (pGS) >= 7, Gleason score (GS) upgrade at RP, tumor volume > 0.5 ml, and Epstein criteria for significant tumor were calculated using multivariate analyses and area under the curve. The base model in multivariate analysis included age, PSA, abnormal digital rectal examination, and biopsy GS. PHI was significantly higher in patients with pT3 or pGS >= 7 (p < 0.001), pT3 disease (p = 0.001), pGS >= 7 (p < 0.001), GS upgrade (p < 0.001), tumor volume > 0.5 ml (p < 0.001), and Epstein criteria for significant tumor (p = 0.001). %p2PSA was also significantly higher in all the above outcomes. The risk of pT3 or pGS >= 7 was 16.1 % for PHI < 35 and 60.8 % for PHI > 35 (sensitivity 84.2 %, specificity of 60.3 %), and the risk of tumor volume > 0.5 ml was 25.5 % for PHI < 35 and 72.6 % for PHI > 35 (sensitivity 79.1 %, specificity 67.2 %). In multivariate analysis, adding %p2PSA or PHI to the base model significantly improved the accuracy (area under the curve) in predicting pT3 or pGS >= 7 (by 7.2-7.9 %), tumor volume > 0.5 ml (by 10.3-12.8 %), and Epstein criteria for significant tumor (by 13.9-15.9 %). Net clinical benefit was observed in decision curve analyses for prediction of both tumor volume > 0.5 ml, and pT3 or pGS >= 7. Both PHI and %p2PSA predict aggressive and significant pathologies in RP in Chinese men. This enabled identification of nonaggressive cancers for better counseling on active surveillance or treatment.
引用
收藏
页码:2707 / 2714
页数:8
相关论文
共 20 条
[1]   Relating biopsy and clinical variables to radical prostatectomy findings: Can insignificant and advanced prostate cancer be predicted in a screening population? [J].
Anast, JW ;
Andriole, GL ;
Bismar, TA ;
Yan, Y ;
Humphrey, PA .
UROLOGY, 2004, 64 (03) :544-550
[2]   Pathology of the prostate in radical cystectomy specimens: A critical review [J].
Autorino, Riccardo ;
Di Lorenzo, Giuseppe ;
Damiano, Rocco ;
Giannarini, Gianluca ;
De Sio, Marco ;
Cheng, Liang ;
Montironi, Rodolfo .
SURGICAL ONCOLOGY-OXFORD, 2009, 18 (01) :73-84
[3]   A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range [J].
Catalona, William J. ;
Partin, Alan W. ;
Sanda, Martin G. ;
Wei, John T. ;
Klee, George G. ;
Bangma, Chris H. ;
Slawin, Kevin M. ;
Marks, Leonard S. ;
Loeb, Stacy ;
Broyles, Dennis L. ;
Shin, Sanghyuk S. ;
Cruz, Amabelle B. ;
Chan, Daniel W. ;
Sokoll, Lori J. ;
Roberts, William L. ;
van Schaik, Ron H. N. ;
Mizrahi, Isaac A. .
JOURNAL OF UROLOGY, 2011, 185 (05) :1650-1655
[4]  
Eminaga O, 2014, UROL ONCOL, V32, P1117
[5]   The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma [J].
Epstein, JI ;
Allsbrook, WC ;
Amin, MB ;
Egevad, LL ;
Bastacky, S ;
Beltrán, AL ;
Berner, A ;
Billis, A ;
Boccon-Gibod, L ;
Cheng, L ;
Civantos, F ;
Cohen, C ;
Cohen, MB ;
Datta, M ;
Davis, C ;
Delahunt, B ;
Delprado, W ;
Eble, JN ;
Foster, CS ;
Furusato, M ;
Gaudin, PB ;
Grignon, DJ ;
Humphrey, PA ;
Iczkowski, KA ;
Jones, EC ;
Lucia, S ;
McCue, PA ;
Nazeer, T ;
Oliva, E ;
Pan, CC ;
Pizov, G ;
Reuter, V ;
Samaratunga, H ;
Sebo, T ;
Sesterhenn, I ;
Shevchuk, M ;
Srigley, JR ;
Suzigan, S ;
Takahashi, H ;
Tamboli, P ;
Tan, PH ;
Têtu, B ;
Tickoo, S ;
Tomaszewski, JE ;
Troncoso, P ;
Tsuzuki, T ;
True, LD ;
van der Kwast, T ;
Wheeler, TM ;
Wojno, KJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) :1228-1242
[6]   PATHOLOGICAL AND CLINICAL FINDINGS TO PREDICT TUMOR EXTENT OF NONPALPABLE (STAGE-T1C) PROSTATE-CANCER [J].
EPSTEIN, JI ;
WALSH, PC ;
CARMICHAEL, M ;
BRENDLER, CB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (05) :368-374
[7]   RADICAL PROSTATECTOMY FOR IMPALPABLE PROSTATE-CANCER - THE JOHNS-HOPKINS EXPERIENCE WITH TUMORS FOUND ON TRANSURETHRAL RESECTION (STAGES T1A AND T1B) AND ON NEEDLE-BIOPSY (STAGE T1C) [J].
EPSTEIN, JI ;
WALSH, PC ;
BRENDLER, CB .
JOURNAL OF UROLOGY, 1994, 152 (05) :1721-1729
[8]   Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study [J].
Fossati, Nicola ;
Buffi, Nicolo Maria ;
Haese, Alexander ;
Stephan, Carsten ;
Larcher, Alessandro ;
McNicholas, Thomas ;
de la Taille, Alexandre ;
Freschi, Massimo ;
Lughezzani, Giovanni ;
Abrate, Alberto ;
Bini, Vittorio ;
Palou Redorta, Joan ;
Graefen, Markus ;
Guazzoni, Giorgio ;
Lazzeri, Massimo .
EUROPEAN UROLOGY, 2015, 68 (01) :132-138
[9]   Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer [J].
Guazzoni, Giorgio ;
Lazzeri, Massimo ;
Nava, Luciano ;
Lughezzani, Giovanni ;
Larcher, Alessandro ;
Scattoni, Vincenzo ;
Gadda, Giulio Maria ;
Bini, Vittorio ;
Cestari, Andrea ;
Buffi, Nicolo Maria ;
Freschi, Massimo ;
Rigatti, Patrizio ;
Montorsi, Francesco .
EUROPEAN UROLOGY, 2012, 61 (03) :455-466
[10]   Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection [J].
Jansen, Flip H. ;
van Schaik, Ron H. N. ;
Kurstjens, Joep ;
Horninger, Wolfgang ;
Klocker, Helmut ;
Bektic, Jasmin ;
Wildhagen, Mark F. ;
Roobol, Monique J. ;
Bangma, Chris H. ;
Bartsch, Georg .
EUROPEAN UROLOGY, 2010, 57 (06) :921-927